Embion will present as an Innovation Showcase finalist at Animal Health, Nutrition & Technology Innovation Europe

Thanks to its proprietary processing technology and high-performance bioactives, Embion Technologies was selected along 31 promising startups to present to an audience of 700+ delegates, including C-suite from companies such as Boehringer Ingelheim, Elanco, Zoetis, as well as investors such as Guggenheim Partners, New Protein Capital and Stifel. The company was chosen by a selection committee of specialists with extensive breadth of experience and knowledge across animal health and nutrition industries.

Animal Health, Nutrition and Technology Innovation Europe, taking place 21-23rd February 2022 in London, is the premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition. It connects businesses with financial investors and strategic corporate partners.

We are looking forward to share our vision and enthusiasm with key players in the industry and promote Embion’s groundbreaking platform technology and innovative solutions for the Animal Health and Nutrition Market.

Learn more about Animal Health, Nutrition and Technology Innovation Europe


Embion Finalist AHNTIE